EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis. - Wikidata - awgldk - TriplyDB

EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis.

EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis.

http://www.wikidata.org/entity/Q33867376

about

Epigenetics of colorectal cancer Cytokine-Induced Modulation of Colorectal Cancer Prognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysis Extensive survey of STAT6 expression in a large series of mesenchymal tumors.Overexpression of nuclear protein kinase CK2 α catalytic subunit (CK2α) as a poor prognosticator in human colorectal cancer.EZH2 depletion blocks the proliferation of colon cancer cells.Prognostic value of polycomb proteins EZH2, BMI1 and SUZ12 and histone modification H3K27me3 in colorectal cancer Clinical and Prognostic Implications of Transcription Factor SOX4 in Patients with Colon Cancer.Essential role of Stat3 in PI3K-induced oncogenic transformation Enhancer of zeste homolog 2 as an independent prognostic marker for cancer: a meta-analysis EZH2 is a sensitive marker of malignancy in salivary gland tumors.Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors.Prognostic significance of EZH2 expression in patients with digestive cancers: a meta-analysis.Prognostic Significance of EZH2 Expression in Non-Small Cell Lung Cancer: A Meta-analysis.Prognostic significance of EZH2 expression in patients with oesophageal cancer: a meta-analysis.The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway Tumor growth suppressive effect of IL-4 through p21-mediated activation of STAT6 in IL-4Rα overexpressed melanoma models.EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.Epigenetic biomarkers in colorectal cancer diagnostics.EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis.Epigenetic biomarkers: potential applications in gastrointestinal cancers Context-dependent actions of Polycomb repressors in cancer.The prognostic values of signal transducers activators of transcription family in ovarian cancer.Epigenetic biomarkers in colorectal cancer: premises and prospects.Targeting histone methylation for colorectal cancer Vitamin D has wide regulatory effects on histone demethylase genes.Elevated expression of MGb2-Ag/TRAK1 is correlated with poor prognosis in patients with colorectal cancer.Polycomb Repressor Complex 2 in Genomic Instability and Cancer STATing the importance of immune modulation by platinum chemotherapeutics.Large variety in a panel of human colon cancer organoids in response to EZH2 inhibition.The role of EZH2 in overall survival of colorectal cancer: a meta-analysis.In aggressive variants of non-Hodgkin lymphomas, Ezh2 is strongly expressed and polycomb repressive complex PRC1.4 dominates over PRC1.2.Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma.Reporting in studies of protein biomarkers of prognosis in colorectal cancer in relation to the REMARK guidelines.Expression and clinicopathological significance of EED, SUZ12 and EZH2 mRNA in colorectal cancer.

P2860

Q24598045-CB4F2382-8A98-403E-8A97-16F5BF9F2C7F Q26752374-D4AFB825-E462-4386-B1EE-E9B036624EA0 Q27853296-7CB11945-CE65-400F-A68F-F17746981548 Q33421985-64D027B6-42DC-4836-ACA0-4E57E2C9698A Q33832029-4ED9DBCB-B5E6-4881-BFAF-635B27BF86D5 Q33963796-64F7A88B-49D8-4799-BE2C-E5D42DBD6414 Q34226978-751D2946-5CE7-48E2-BFAB-67B23891E278 Q34796489-B184036E-C66C-4184-B9B8-9D56DF0D0445 Q35164627-8CBD4564-B0E3-42CA-B69D-CEC40EF605BC Q35606640-74BAB88B-C9DF-4A42-AC9B-C359A45C5ABC Q36071043-03B4BF40-3B8F-4BD8-B2C1-8B9E1CE576FB Q36217858-E40EECBC-ECEB-47AA-B528-290A9C852416 Q36317813-F8F7DC9C-B05B-4560-961B-31A6526136C4 Q36453727-718E4FA4-AAC1-444B-807B-EAB73AE1F6FC Q36797474-FAD78A64-6889-4D6A-A9E5-60466A84092F Q37022273-D70496C2-5301-4D93-A358-DF9614780E8D Q37269038-D6938846-114D-4571-A853-25520C68F9E1 Q37472017-B9737959-D4A9-4569-A886-2BB43DECED44 Q38018997-932FF40D-087E-49E7-AB4B-7B66FF504125 Q38019814-A172B93F-33E3-4BA8-89EF-F60394A14BF0 Q38204377-2FB70547-F91D-4B28-8E1E-2A4E259A52D0 Q38518851-0BE4163B-6DF5-46D5-8FE5-3169502D9894 Q38768270-486F48B3-679A-493A-97CA-DCB09B564CFD Q38992809-CF355BBE-9CFF-4F8C-BB89-C19FEFA226C5 Q39175486-6DF2AE85-3C62-4E1A-8183-92A929DCC76C Q39389302-35054F08-5391-4E6C-9037-2628C78E5D53 Q39542066-2B00AFEB-F6D1-46D5-BBA9-D23C4D79562E Q41573279-2ECB902D-379B-462E-A213-EBEC763B0FD5 Q42042935-C17C5E25-0D07-4F09-BDF2-9A4C1B8F5ABE Q42317490-AF3920E1-E68F-406F-957D-06BF3D7F0F68 Q46732136-CF912695-856E-4557-9664-3473688C8A79 Q47771456-501E2A75-2FF7-43D5-B7D0-10189EF67DF9 Q49206365-7202F96C-12D2-47D8-83CC-28B6440AB704 Q53584232-8BF16912-D9CA-483F-878A-1CB4B6BB6065 Q54188074-5770891C-A89C-4D03-8A75-30E7AD0C2903

P2860

EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis.

http://www.wikidata.org/entity/Q33867376

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

EZH2 and STAT6 expression prof ...... al cancer stage and prognosis.

@ast

EZH2 and STAT6 expression prof ...... al cancer stage and prognosis.

@en

type

label

EZH2 and STAT6 expression prof ...... al cancer stage and prognosis.

@ast

EZH2 and STAT6 expression prof ...... al cancer stage and prognosis.

@en

prefLabel

EZH2 and STAT6 expression prof ...... al cancer stage and prognosis.

@ast

EZH2 and STAT6 expression prof ...... al cancer stage and prognosis.

@en

P1433

Q33867376-61EFD2D2-56E5-4E5E-A0A3-AB68E57399D5

P1476

Q33867376-D8C14470-DB5E-4750-AACE-43062F0176C2

P2093

Q33867376-12F4C3FA-8734-4D69-B353-D11B367672BD

Q33867376-37AF8304-8AB5-435D-89C3-0AB45B755574

Q33867376-5FD69772-A595-4423-9A4E-1E57C73CE144

Q33867376-6112FA2B-3DA4-4B86-A533-1791CD41340B

Q33867376-B6D66398-8266-4342-8466-B0D7B5FFE030

Q33867376-E307A83B-0CF6-4384-AA24-DBE0AFC3E1D5

P2860

Q33867376-09755B9B-6028-4AA0-BA0A-481DAC9C9B00

Q33867376-2DD140E0-76FC-4338-AEE5-30BDE3B3D6D6

Q33867376-33DF5EFB-36EA-446A-8FCF-AA9F3E0DB8D1

Q33867376-35C94050-3D2E-4140-8DAF-1B6826E09084

Q33867376-41EC7EA3-3499-43A3-B817-69255C08D500

Q33867376-426F1AF3-10E1-4D6E-9FF2-C15F91862520

Q33867376-51D66E0E-D867-4B27-BD8F-B8E437EB4650

Q33867376-8FE701E5-E561-43D8-974A-3382348CF8A5

Q33867376-92FA4AF8-5398-447A-9FE0-F584717E2968

Q33867376-95D39BF3-9566-4F98-BA8C-E1D084A63781

P304

Q33867376-8CB1FB4A-932C-475A-BBEF-975AD623AC04

P31

Q33867376-B99F65C6-42B7-49CC-918B-6DE3CF59ECDD

P356

Q33867376-69A609BF-F816-4971-AC54-FA922C48CCE7

P407

Q33867376-CCC9BC31-8510-45FA-B1CF-3679C9EA8C8B

P433

Q33867376-40413A39-5BF0-4802-B54E-8AD4EC92C98A

P478

Q33867376-BA0DD42E-AFAC-411C-8292-4AFC862A0B95

P577

Q33867376-A731B20B-A3E2-4A80-9853-06C2E239D7C2

P698

Q33867376-25AC0E4E-87C4-414D-AA72-F6CE6C63905B

P921

Q33867376-A70E6DF0-3258-4D23-BAAD-49E1486305D2

P932

Q33867376-934CF2B6-B933-4A4E-989B-EECE3830AE97

P356

WJG.V16.I19.2421

P1433

World Journal of Gastroenterology

P1476

EZH2 and STAT6 expression prof ...... al cancer stage and prognosis.

@en

P2093

Cheng-Gang Wang

http://www.w3.org/2001/XMLSchema#string

Fang-Fang Liu

http://www.w3.org/2001/XMLSchema#string

Hui Zhang

http://www.w3.org/2001/XMLSchema#string

Jing Yuan

http://www.w3.org/2001/XMLSchema#string

Shan Wang

http://www.w3.org/2001/XMLSchema#string

Ying-Jiang Ye

http://www.w3.org/2001/XMLSchema#string

P2860

Mammalian homologues of the Polycomb-group gene Enhancer of zeste mediate gene silencing in Drosophila heterochromatin and at S. cerevisiae telomeres

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

The polycomb group protein EZH2 is involved in progression of prostate cancer

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

Signaling mechanisms, interaction partners, and target genes of STAT6.

Expression of Bmi-1 is a prognostic marker in bladder cancer

STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells

Signal transducer and activator of transcription 6 (Stat6) and CD1: inhibitors of immunosurveillance against primary tumors and metastatic disease.

Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease.

P304

2421-2427

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V16.I19.2421

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20480530

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

2874149

http://www.w3.org/2001/XMLSchema#string